The Global Biocompatible 3D Printing Materials Market is expected to grow from USD 525.85 million in 2022 to USD 1751.73 million by 2028 at a healthy CAGR of 22.2% during the forecast period of 2023-2028.
Market Drivers:
The global biocompatible 3D printing materials market drivers include the following factors:
Advancements in 3D Printing Technology: 3D printing technology has revolutionized the 3d printing market, enabling the production of customized and complex structures with precise control over designs, multi-material capabilities, and integration of bioactive agents. 3D printing technology is preferred to generate medical structures since it improves the product-performance and can meet specific requirements and offer safe and reliable products.
Growing Medical Applications: Medical applications use biocompatible 3D printing materials in manufacturing implants, prosthetics, tissues, etc. to guarantee safe interaction with the human body. For instance, in February 2023, a US-based 3D printer and material maker Stratasys announced the launch of dentures made with a new biocompatible resin material in realistic color and tooth detail. 3D-printed permanent dentures aim to reduce cost.